[go: up one dir, main page]

AR095483A1 - Composición y método para prevenir, reducir, aliviar o tratar el vómito idiopático - Google Patents

Composición y método para prevenir, reducir, aliviar o tratar el vómito idiopático

Info

Publication number
AR095483A1
AR095483A1 ARP140101087A ARP140101087A AR095483A1 AR 095483 A1 AR095483 A1 AR 095483A1 AR P140101087 A ARP140101087 A AR P140101087A AR P140101087 A ARP140101087 A AR P140101087A AR 095483 A1 AR095483 A1 AR 095483A1
Authority
AR
Argentina
Prior art keywords
vomit
relief
composition
prevent
reduce
Prior art date
Application number
ARP140101087A
Other languages
English (en)
Inventor
Hu Ping
Ann Reinsalu Lori
Lin Yakang
Soon Park Jean
Original Assignee
Iams Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iams Co filed Critical Iams Co
Publication of AR095483A1 publication Critical patent/AR095483A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Las composiciones que contiene u no o más compuestos con efecto inhibidor en un receptor de 5-hidroxitriptamina-3a-serotonina (5-HT₃ₐ) y/o neurocinina-1 (NK-1) son eficaces para prevenir o tratar el vómito idiopático en un mamífero.
ARP140101087A 2013-03-15 2014-03-14 Composición y método para prevenir, reducir, aliviar o tratar el vómito idiopático AR095483A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361786485P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
AR095483A1 true AR095483A1 (es) 2015-10-21

Family

ID=50391367

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140101087A AR095483A1 (es) 2013-03-15 2014-03-14 Composición y método para prevenir, reducir, aliviar o tratar el vómito idiopático

Country Status (10)

Country Link
US (1) US10548935B2 (es)
EP (1) EP2986136B1 (es)
JP (2) JP6300897B2 (es)
CN (2) CN105188400B (es)
AR (1) AR095483A1 (es)
AU (2) AU2014228552A1 (es)
CA (1) CA2902827C (es)
ES (1) ES2825064T3 (es)
RU (1) RU2715699C2 (es)
WO (1) WO2014143539A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6215443B2 (ja) 2013-03-15 2017-10-18 マース インコーポレーテッドＭａｒｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 特発性嘔吐を予防、低減、緩和または治療する組成物および方法
JP6992057B2 (ja) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法
CN108002997B (zh) * 2017-12-15 2020-10-23 中国医学科学院药用植物研究所海南分所 一种具有止呕作用的沉香提取物及其应用
EP3826621A1 (en) * 2018-07-24 2021-06-02 Hlxth B.V. Chalcones and derivatives for use in medicaments and nutraceuticals
TWI874418B (zh) * 2019-07-02 2025-03-01 美商瑪斯公司 動物食物組合物
CN111329866B (zh) * 2020-04-12 2023-04-07 云南民族大学 一种五环三萜类化合物在制备抗偏头痛药物中的应用
CN114984001B (zh) * 2022-06-23 2023-06-13 重庆医科大学附属第二医院 格隆溴铵在制备用于预防恶心和呕吐症状的药物中的用途
CN119185265A (zh) * 2024-11-15 2024-12-27 辽宁新中现代医药有限公司 倍半萜类化合物在缓解恶心呕吐中的应用
CN119454678B9 (zh) * 2024-11-18 2025-10-31 中国农业科学院北京畜牧兽医研究所 植物提取物在制备抗犬冠状病毒的药物中的应用

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773930A (en) 1971-03-23 1973-11-20 Johnson & Johnson Amino acid composition
US3810994A (en) 1972-06-01 1974-05-14 Ethyl Corp Method and composition for treating obesity
US4006266A (en) 1975-10-08 1977-02-01 The Quaker Oats Company Process for making a dry pet food having a hard component and a soft component
US4070488A (en) 1975-11-25 1978-01-24 Davis Rachel D Nutritive composition
GB1583644A (en) 1977-08-18 1981-01-28 Spillers Ltd Pet food
US4371558A (en) 1981-02-11 1983-02-01 Liggett Group Inc. Semi-moist dog food preparation
US4414238A (en) 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet
US4497800A (en) 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition
DE3645254C2 (de) 1986-08-01 1994-06-09 Mattern Geb Eckhardt Claudia Arzneimittel gegen Schwangerschaftsübelkeit und -erbrechen
US4892748A (en) 1988-06-20 1990-01-09 David Piatt & Associates Low calorie pet treat
US5017389A (en) 1988-08-16 1991-05-21 Green Scott T Nutritional drink compositions
US5173214A (en) 1989-02-01 1992-12-22 Union Oil Company Of California Precursor composition for sols and gels
US5141755A (en) 1991-05-29 1992-08-25 Weisman Eric H Reduced animal product pet food composition
US5217740A (en) 1991-08-13 1993-06-08 Purina Mills, Inc. High moisture ration
JPH0759517A (ja) 1993-08-24 1995-03-07 Matsutani Chem Ind Ltd 肥満予防効果を有するペットフード
JP3724043B2 (ja) 1995-03-30 2005-12-07 ぺんてる株式会社 描画材組成物
US5962043A (en) 1996-02-29 1999-10-05 Seal Rock Technologies Incorporated Weight reduction method for dogs and other pets
JPH10158183A (ja) 1996-11-26 1998-06-16 Wakunaga Pharmaceut Co Ltd 二日酔いの予防および治療用組成物
US6203797B1 (en) 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6117477A (en) 1998-03-18 2000-09-12 Kal Kan Foods, Inc. Multicomponent food product and methods of making and using the same
US6288116B1 (en) 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
GB9812426D0 (en) 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
NZ508798A (en) 1998-06-26 2003-03-28 Iams Company Pet food composition comprising L-carnitine, and its use in the manufacture of pet food products for promoting weight loss and/or increasing lean body mass and/or enhancing the satiety and decreasing voluntary food intake in overweight dogs
BR9914594A (pt) 1998-10-16 2001-06-26 Nestle Sa Matéria protéica de digestão diminuìda e sua utilização
US6403142B1 (en) 1998-12-11 2002-06-11 Ralston Purina Company Hypoallergenic pet food
DE19900476A1 (de) 1999-01-08 2000-07-13 Ruediger Bode Flüssiges Futtermittel oder Zusatzfuttermittel
MXPA01008598A (es) * 1999-02-24 2003-06-24 Szabo Joseph Composiciones y metodos dieteticos.
BR0008774A (pt) 1999-03-05 2002-02-13 Iams Company Processos para conservar a massa muscular esqueletal de um cão geriátrico, para melhorar a composição do corpo de um cão geriátrico e para reduzir a gordura do corpo de um cão geriátrico
US6071544A (en) 1999-04-01 2000-06-06 The Iams Company Dietary compositions and method for promoting healthy weight loss cats
US6270820B1 (en) 2000-02-04 2001-08-07 Ralston Purina Company Process for dry stable intermediate pet food composition
US6579542B1 (en) 2000-03-02 2003-06-17 Cecil Faulkner Treating feline-specific disorders by orally administering Hydrastis canadensis
CN1188142C (zh) 2000-08-16 2005-02-09 钟梓光 一种治疗霍乱的药物
US20030194423A1 (en) * 2002-04-15 2003-10-16 Mars, Inc. Composition for enhancing nutritional content of food
EP1622915B1 (en) * 2003-04-08 2008-08-06 Flexitral, Inc. Fragrance compositions comprising benzo ¬4,5 thieno¬3,2-b pyran-2-one
JP2004359550A (ja) 2003-06-02 2004-12-24 Pigeon Corp つわり緩和性混合ハーブおよびハーブティー
US7687077B2 (en) 2003-11-26 2010-03-30 Hill's Pet Nutrition, Inc. Method to reduce stool odor of companion animals
EP1694136B1 (en) 2003-11-26 2011-12-21 Hill's Pet Nutrition, Inc. Method to reduce odor of excreta from companion animals
US20060008511A1 (en) 2004-07-08 2006-01-12 Jhy-Jhu Lin Probiotic products for pet applications
AU2005330525B2 (en) * 2004-10-14 2012-03-08 Adventures Plus Pty Ltd A method for the treatment of gastrointestinal and other disorders with an admixture of vitamins and minerals
FR2877339B1 (fr) 2004-11-03 2008-10-31 Mane Fils Sa V Gamma-undecenolactone, procede de preparation et utilisations
CA2587406A1 (en) 2004-11-16 2006-05-26 Limerick Neurosciences, Inc. Methods and compositions for treating pain
WO2006094154A2 (en) 2005-03-02 2006-09-08 Hill's Pet Nutrition, Inc. Methods and systems for designing animal food compositions
CN1291753C (zh) 2005-04-13 2006-12-27 南京金盾动物药业有限责任公司 一种兽用止吐药物及其制备方法
US7867540B2 (en) 2005-07-19 2011-01-11 Mars, Inc. Aroma composition and method
HRPK20060416B3 (en) 2006-11-29 2010-04-30 Juroš Ante Herbal mixture and an active substance originating thereof, for enhancing immunity and improving medical treatment
JP2008163233A (ja) 2006-12-28 2008-07-17 Oji Paper Co Ltd 制吐剤
AU2008230747A1 (en) 2007-03-27 2008-10-02 The Procter & Gamble Company Methods and kits for administering probiotics
JP2010030963A (ja) 2008-07-30 2010-02-12 Kowa Co 消化管運動賦活調整剤
AU2010225923B2 (en) * 2009-03-16 2016-10-27 Ipintl, Llc Treating Alzheimer's disease and osteoporosis and reducing aging
EP2263664A1 (en) * 2009-05-18 2010-12-22 Nestec S.A. Opioid receptors stimulating compounds (thymoquinone, Nigella sativa) and food allergy
CN105663146B (zh) * 2009-08-14 2020-09-11 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
WO2011066289A1 (en) * 2009-11-30 2011-06-03 Eurand, Inc. Ondansetron orally disintegrating tablet compositions for prevention of nausea and vomiting
CN107050401A (zh) * 2009-12-29 2017-08-18 希尔氏宠物营养品公司 用于改善或预防炎性病况的包含姜的组合物
US20110159500A1 (en) 2009-12-29 2011-06-30 Hill's Pet Nutrition, Inc. Compositions including ginger for the amelioration or prevention of inflammatory conditions
CN101721675A (zh) 2010-01-20 2010-06-09 黄泳葛 一种止吐、防晕、防暑、养胃的药物
EP2366292A1 (en) * 2010-03-15 2011-09-21 Nestec S.A. Artificial sweeteners and performance
CN102217721A (zh) 2010-04-14 2011-10-19 杨长军 一种波斯猫饲养料
CN101874894B (zh) 2010-04-23 2012-04-18 泰一和浦（北京）中医药研究院有限公司 一种治疗呕吐的中药组合物及其制备方法
CN101829307B (zh) 2010-05-28 2013-05-08 辽宁省中医药研究院 一种治疗癌症化疗后消化道副作用的药物
CN102283926A (zh) 2010-06-17 2011-12-21 苏州知微堂生物科技有限公司 一种左金丸整合型新剂型制备技术及其生产方法
US20110311684A1 (en) * 2010-06-21 2011-12-22 James Rea Foods and beverages for pregnancy and lactation
CN102406735A (zh) 2010-12-28 2012-04-11 江西青峰药业有限公司 水煎煮提取的枳实或枳壳总黄酮提取物及其用途
CN102133385A (zh) * 2011-03-02 2011-07-27 青岛大学 生姜与白胡椒组合物、其制备方法及其在制备癌症放、化疗中减毒增效药物中的用途
CN102166335A (zh) * 2011-03-31 2011-08-31 青岛大学 生姜与荜拨组合物、其制备方法及其在制备癌症放、化疗中减毒增效药物中的用途
KR20120118102A (ko) 2011-04-18 2012-10-26 차대헌 알칼리환원수를 이용하여 울금즙을 제조하는 방법 및 상기방법으로 제조된 울금즙
CN102198259A (zh) 2011-05-05 2011-09-28 孙福玲 一种治疗呕吐的中药组合物
US20120329736A1 (en) * 2011-06-24 2012-12-27 Huang Alexander L Treatment for gastrointestinal disorders using a selective, site-activated binding system
CN102370096B (zh) 2011-09-24 2015-11-25 长治市雄丰清真养殖屠宰有限公司 预防牛羊呕吐的饲料
CN102671058B (zh) 2012-06-04 2014-05-14 陈慧珊 治疗呕吐中药口服液及制备方法
CN102657841A (zh) * 2012-06-08 2012-09-12 桂林三金药业股份有限公司 一种生姜酚类提取物制剂及其制备方法
JP6215443B2 (ja) 2013-03-15 2017-10-18 マース インコーポレーテッドＭａｒｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 特発性嘔吐を予防、低減、緩和または治療する組成物および方法

Also Published As

Publication number Publication date
WO2014143539A1 (en) 2014-09-18
EP2986136B1 (en) 2020-08-12
CN118105365A (zh) 2024-05-31
RU2715699C2 (ru) 2020-03-03
JP6300897B2 (ja) 2018-03-28
CN105188400B (zh) 2024-04-05
RU2015144027A (ru) 2017-04-26
JP2018076335A (ja) 2018-05-17
CA2902827A1 (en) 2014-09-18
EP2986136A1 (en) 2016-02-24
US10548935B2 (en) 2020-02-04
AU2019200490A1 (en) 2019-02-14
AU2014228552A1 (en) 2015-10-08
ES2825064T3 (es) 2021-05-14
JP2016513639A (ja) 2016-05-16
CA2902827C (en) 2022-11-01
CN105188400A (zh) 2015-12-23
AU2019200490B2 (en) 2021-01-28
US20140271949A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
AR095483A1 (es) Composición y método para prevenir, reducir, aliviar o tratar el vómito idiopático
CL2016000326A1 (es) Composiciones y método para tratar condiciones asociadas con el complemento
UY37134A (es) Compuestos heteroarilos y composiciones que los contienen útiles como inhibidores de pad4
PH12016500511A1 (en) Selective grp94 inhibitors and uses thereof
ECSP17020133A (es) Derivados de benzodiazepina citotóxicos
MX2021008044A (es) Metodos para el tratamiento de condiciones asociadas con la activacion del complemento dependiente de masp-2.
MX2018008052A (es) Inhibidores de desmetilasa especifica de lisina 1 (lsd1).
MX2022007472A (es) Uso de plinabulina en combinacion con inhibidores de punto de control inmunitario.
EA201692204A1 (ru) Композиции и способы модулирования экспрессии фактора комплемента b
MX369863B (es) Ciertas entidades quimicas, composiciones y metodos.
PH12015502659A1 (en) Surface treatment compositions comprising photochromic dyes
MX376916B (es) Composiciones para el tratamiento de espasmos gastrointestinales.
EA201690582A1 (ru) Модуляторы фактора в комплемента
UA118558C2 (uk) Пептидна сполука
AR100498A1 (es) Mejora en la reducción de la fricción
CL2016001415A1 (es) Composiciones farmacéuticas que comprenden fumarato de dimetilo
EA201591137A1 (ru) Ингибиторы mk2 и их применения
UA116146C2 (uk) Фунгіцидні суміші і, які містять фунгіциди стробілуринового типу
MX377534B (es) Compuestos para usarse en el tratamiento de hiperinsulinemia.
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX377002B (es) Cd33 soluble para tratar síndromes mielodisplásicos (mds).
PE20151435A1 (es) Laquinimod para reducir el dano talamico en la esclerosis multiple
PE20160473A1 (es) Composiciones para tratamiento de aguas y metodos para uso de las mismas
MX386861B (es) Composiciones inhibidoras de nitrificación microencapsuladas.

Legal Events

Date Code Title Description
FB Suspension of granting procedure